FDA and NIH Don’t Always Enforce Clinical Trial Transparency Regulations
Recently, Science magazine reviewed more than 4,700 clinical trials whose results should have been posted on the National…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Monthly Archives
February 2020
John Kamp Inducted into the Medical Advertising Hall of Fame
Last week, it was announced that John Kamp would be inducted into the Medical Advertising Hall of Fame as “the industry’s…
Blue Cross Blue Shield Invests in Nonprofit Aimed at Cheaper Drugs
The Blue Cross Blue Shield Association (BCBSA) and eighteen of its member organizations have agreed to invest $55 million in a…
FDA Announces Plan for Coronavirus Countermeasures
With Coronavirus deaths now over 1,000, the US Food and Drug Administration (“FDA”) announced actions to advance the development…
Whistleblower Suits Signal New Generation of EHR Fraud
The US Department of Justice (“DOJ”) is currently weighing whether to intervene in a whistleblower suit brought against Community…
High Expectations For New Biosimilars About to Hit Market
With recent concerns about the skyrocketing cost of prescription drugs and biologics, attention has turned to whether the…
Vaping and Teens Online Course offers Clinicians Practical Guidance on…
To assist healthcare providers, understand the emerging health threat of teen vaping, Rockpointe, a leader in Continuing Medical…
What Constitutes Pay-for-Delay?
In January, oral arguments in the 3rd Circuit Court of Appeals case between the Federal Trade Commission (FTC) and AbbVie delved…
HHS OIG Issues Advisory Opinion on Provider-Paid Travel for Rare Disease…
On January 21, 2020, the United States Department of Health and Human Services Office of Inspector General (HHS OIG) posted OIG…
Patient Services, Inc. Settlement and Corporate Integrity Agreement
Recently, the US Department of Justice (“DOJ”) announced that it has reached an agreement with Patient Services, Inc., (“PSI”), a…